You are here: Industry Insights > hydroxychloroquine

News List

MHRA suspends COVID-19 hydroxychloroquine trials pharmatimes
June 17, 2020
As of this morning – Wednesday June 17 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 298,136 with 41,969 deaths.
US FDA revokes EUA for chloroquine and hydroxychloroquine expresspharma
June 17, 2020
The known and potential benefits of chloroquine and hydroxychloroquine no longer outweigh the known and potential risks for the authorised use, said the drug regulator.
Hydroxychloroquine fails as postexposure prophylaxis for COVID-19 pharmatimes
June 08, 2020
Researchers have found that giving hydroxychloroquine as postexposure prophylaxis for COVID-19 did not prevent illness.
The Lancet retracts study linking hydroxychloroquine with deaths pharmatimes
June 08, 2020
The Lancet has issued a statement that a study which indicated that hydroxychloroquine was linked with higher rates of death in COVID-19 patients has been retracted, after three of its authors said they were unable to 'vouch for the veracity of the primar
WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns expresspharma
May 26, 2020
Dr Mike Ryan, head of the WHO emergencies programme, said the decision to suspend trials of hydroxychloroquine had been taken out of “an abundance of caution”.
First UK healthcare worker to enrol in COVID-19 prevention trial pharmatimes
May 21, 2020
The first UK frontline NHS worker will today enrol in a new study designed to test the potential of hydroxychloroquine to prevent infection with novel coronavirus.
Phase IIb trial to study hydroxychloroquine and azithromycin as COVID-19 treatment launched europeanpharmaceuticalreview
May 19, 2020
A double-blind clinical trial has begun in the US to study hydroxychloroquine and azithromycin treatment in patients with COVID-19.
India to send medicines to 25 African countries expresspharma
May 11, 2020
The medicines include hydroxychloroquine, paracetamol and other drugs which are immediately required to fight the novel coronavirus pandemic.
CDMO pledges increased production of hydroxychloroquine sulfate, potential COVID-19 treatment europeanpharmaceuticalreview
May 08, 2020
The CDMO AMRI has said it will boost its production of the malaria drug hydroxychloroquine sulfate, identified as a potential COVID-19 treatment, following an emergency use authorisation from the FDA.
AMRI Increases HCQ Production in U.S. contractpharma
May 05, 2020
Contract research, development and manufacturing organization, AMRI, said in the immediate and near term, it is increasing production of hydroxychloroquine sulfate active pharmaceutical ingredient (API).

Previous page 1 2 3 4 5 6 Next page